Toronto pharma startup Antibe Therapeutics completes final closing of private placement bringing total proceeds to $2.7M
Antibe Therapeutics Completes Final Closing of Private Placement Bringing Total Proceeds to $2.7 Million - Antibe Therapeutics Inc.
TORONTO, ONTARIO - (December 21, 2016) - Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV: ATE) closed the second and final closing of its previously announced private placement of units (the "Offering"). The Company raised gross proceeds of $297,750 in the second closing of the Offering, bringing the total gross proceeds of the Offering up to $2,724,495 including the first closing announced on December 16, 2016.
Join in on the conversation with Zayna Khayat when you subscribe to Toronto Health.